SCHEMBL13870914

SCHEMBL13870914

COc1cccc(-c2ccc3c(C)c(C)c(C)cc3n2)c1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAP4K4 O95819 1/20 0.48
SMN1; SMN2 Q16637 4/20 0.47
KDM4E B2RXH2 4/20 0.47
ALDH1A1 P00352 2/20 0.47
TOP1 P11387 1/20 0.45
MAPT P10636 4/20 0.44
RAB9A P51151 3/20 0.44
NFKB1 P19838 1/20 0.44
NFKB2 Q00653 1/20 0.44
RELA Q04206 1/20 0.44
TDP1 Q9NUW8 1/20 0.44
RXFP1 Q9HBX9 1/20 0.43
NPC1 O15118 2/20 0.43
WDR5 P61964 1/20 0.43
TP53 P04637 1/20 0.43
HPGD P15428 1/20 0.43
CASP1 P29466 1/20 0.43
CASP7 P55210 1/20 0.43
HSD17B10 Q99714 1/20 0.43
CYP1A2 P05177 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13870891 0.83 MAP4K4 (0.48) MAP4K4SMN1; SMN2KDM4EALDH1A1TOP1
SCHEMBL13870900 0.82 BCHE (0.41) SMN1; SMN2KDM4EALDH1A1MAPTRAB9A
SCHEMBL13870903 0.81 MAP4K4 (0.51) MAP4K4SMN1; SMN2KDM4EALDH1A1TOP1
SCHEMBL13870924 0.79 SMN1; SMN2 (0.66) MAP4K4SMN1; SMN2KDM4EALDH1A1TOP1
SCHEMBL13399639 0.77 MAPT (0.47) MAP4K4SMN1; SMN2KDM4EALDH1A1TOP1
SCHEMBL13399461 0.77 MAP4K4 (0.47) MAP4K4SMN1; SMN2KDM4EALDH1A1TOP1
SCHEMBL13870941 0.77 SMN1; SMN2 (0.52) MAP4K4SMN1; SMN2KDM4EALDH1A1TOP1
SCHEMBL13870917 0.76 NPC1 (0.47) SMN1; SMN2KDM4EALDH1A1MAPTRAB9A
SCHEMBL16488123 0.76 MAP4K4 (0.46) MAP4K4SMN1; SMN2KDM4EALDH1A1TOP1
SCHEMBL29470234 0.75 DYRK1A (0.58) MAP4K4SMN1; SMN2KDM4EALDH1A1TOP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8956737-B2 Red phosphorescent compound and organic electroluminescent device using the same LG DISPLAY CO., LTD. (KR) 2015-02-17 US disclosed
US-8956737-B2 Red phosphorescent compound and organic electroluminescent device using the same LG DISPLAY CO., LTD. (KR) 2015-02-17 US disclosed
US-20090085476-A1 RED PHOSPHORESCENT COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE USING THE SAME LG DISPLAY CO., LTD. (KR) 2009-04-02 US disclosed
US-20090085476-A1 RED PHOSPHORESCENT COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE USING THE SAME LG DISPLAY CO., LTD. (KR) 2009-04-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090085476-A1 RED PHOSPHORESCENT COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE USING THE SAME IK, G6PD, EYA2 MAP4K4 3011/4885SMN1; SMN2 4169/4885KDM4E 2874/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.